Shanghai Sanyou Medical Co Ltd (688085) - Total Liabilities
Based on the latest financial reports, Shanghai Sanyou Medical Co Ltd (688085) has total liabilities worth CN¥247.79 Million CNY (≈ $36.26 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Shanghai Sanyou Medical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Shanghai Sanyou Medical Co Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Shanghai Sanyou Medical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 688085 asset base.
Shanghai Sanyou Medical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shanghai Sanyou Medical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
JBG SMITH Properties
NYSE:JBGS
|
USA | $2.70 Billion |
|
Anpec Electronics
TWO:6138
|
Taiwan | NT$1.74 Billion |
|
Zhejiang Jasan Holding Group Co Ltd
SHG:603558
|
China | CN¥1.57 Billion |
|
BYBON Group Co Ltd Class A
SHE:300736
|
China | CN¥48.15 Million |
|
Huatian Hotel Group Co Ltd
SHE:000428
|
China | CN¥3.65 Billion |
|
The Oncology Institute, Inc.
NASDAQ:STLN
|
USA | $203.15 Million |
|
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
|
China | CN¥1.08 Billion |
|
PT Bukalapak.com
JK:BUKA
|
Indonesia | Rp717.57 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Shanghai Sanyou Medical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 688085 equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Sanyou Medical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Sanyou Medical Co Ltd (2016–2024)
The table below shows the annual total liabilities of Shanghai Sanyou Medical Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥257.91 Million ≈ $37.74 Million |
+17.88% |
| 2023-12-31 | CN¥218.80 Million ≈ $32.02 Million |
-21.40% |
| 2022-12-31 | CN¥278.35 Million ≈ $40.73 Million |
+6.69% |
| 2021-12-31 | CN¥260.90 Million ≈ $38.18 Million |
+91.49% |
| 2020-12-31 | CN¥136.25 Million ≈ $19.94 Million |
+19.87% |
| 2019-12-31 | CN¥113.67 Million ≈ $16.63 Million |
+135.16% |
| 2018-12-31 | CN¥48.34 Million ≈ $7.07 Million |
+3.34% |
| 2017-12-31 | CN¥46.78 Million ≈ $6.84 Million |
+138.84% |
| 2016-12-31 | CN¥19.58 Million ≈ $2.87 Million |
-- |
About Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more